These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26439506)

  • 1. Infection: PrEParation to be PROUD of.
    Stone L
    Nat Rev Urol; 2015 Nov; 12(11):596. PubMed ID: 26439506
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral chemoprophylaxis: PROUD and pragmatism.
    Mayer KH; Beyrer C
    Lancet; 2016 Jan; 387(10013):6-7. PubMed ID: 26364262
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Preexposure tenofovir-emtricitabine reduced HIV infection in men who have unprotected anal sex with men.
    Sacks HS
    Ann Intern Med; 2016 Jan; 164(2):JC3. PubMed ID: 26784493
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV moments and pre-exposure prophylaxis.
    Grant RM; Glidden DV
    Lancet; 2016 Apr; 387(10027):1507-1508. PubMed ID: 27115970
    [No Abstract]   [Full Text] [Related]  

  • 5. [HIV pre-exposure prophylaxis does not increase the rate of STI].
    Blondel N
    Rev Med Suisse; 2016 Jan; 12(503):236. PubMed ID: 26939198
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV moments and pre-exposure prophylaxis--Authors' reply.
    Dunn DT; Gafos M; White E; McCormack S
    Lancet; 2016 Apr; 387(10027):1508. PubMed ID: 27115971
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
    McCormack S; Dunn DT; Desai M; Dolling DI; Gafos M; Gilson R; Sullivan AK; Clarke A; Reeves I; Schembri G; Mackie N; Bowman C; Lacey CJ; Apea V; Brady M; Fox J; Taylor S; Antonucci S; Khoo SH; Rooney J; Nardone A; Fisher M; McOwan A; Phillips AN; Johnson AM; Gazzard B; Gill ON
    Lancet; 2016 Jan; 387(10013):53-60. PubMed ID: 26364263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progression of STI noted after initiation of EPESE for HIV].
    Schmutz JL
    Ann Dermatol Venereol; 2019 Oct; 146(10):687-688. PubMed ID: 31229351
    [No Abstract]   [Full Text] [Related]  

  • 9. Informal PrEP: an emerging need for nomenclature.
    Brisson J; Ravitsky V; Williams-Jones B
    Lancet Public Health; 2019 Feb; 4(2):e83. PubMed ID: 30578132
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV preexposure prophylaxis in Canadian primary care and community settings.
    Heendeniya A; Tumarkin E; Bogoch II
    Can Fam Physician; 2019 Apr; 65(4):271-272. PubMed ID: 30979761
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.
    Trang TP; Dong BJ; Kojima N; Klausner JD
    Expert Opin Drug Saf; 2016 Sep; 15(9):1287-94. PubMed ID: 27391203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are 2 million bottles of PrEP an empty gesture?
    The Lancet Hiv
    Lancet HIV; 2019 Aug; 6(8):e483. PubMed ID: 31300327
    [No Abstract]   [Full Text] [Related]  

  • 13. Pre-exposure Prophylaxis in Primary Care--A New Era in HIV Prevention.
    Petroll AE; Staden RA; Westergaard RP
    WMJ; 2016 Feb; 115(1):6-8. PubMed ID: 27057572
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis.
    Knox DC; Anderson PL; Harrigan PR; Tan DH
    N Engl J Med; 2017 Feb; 376(5):501-502. PubMed ID: 28146652
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV preexposure prophylaxis for adolescents and young adults.
    Allen E; Gordon A; Krakower D; Hsu K
    Curr Opin Pediatr; 2017 Aug; 29(4):399-406. PubMed ID: 28598901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scotland's approval of PrEP creates postcode lottery in UK, say campaigners.
    Christie B
    BMJ; 2017 Apr; 357():j1834. PubMed ID: 28400382
    [No Abstract]   [Full Text] [Related]  

  • 17. PrEP, Truvada, and Gilead.
    Jack A
    BMJ; 2016 Sep; 354():i4800. PubMed ID: 27609216
    [No Abstract]   [Full Text] [Related]  

  • 18. [Not Available].
    Nau JY
    Rev Med Suisse; 2016 Aug; 12(526):1346-1347. PubMed ID: 28671781
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethical considerations for new HIV prevention trials.
    Sugarman J; Celum CL; Donnell D; Mayer KH
    Lancet HIV; 2019 Aug; 6(8):e489-e491. PubMed ID: 31221591
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV Prevention Drug's Slow Uptake Undercuts Its Early Promise.
    Tuller D
    Health Aff (Millwood); 2018 Feb; 37(2):178-180. PubMed ID: 29401032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.